Author:
Kashlan Reem,Slater Kristin,Garber Martin E.,Kartono Francisca
Reference7 articles.
1. Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis;Mease;N Engl J Med,2014
2. Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study;Deodhar;Lancet,2018
3. Paradoxical reactions: anti-tumor necrosis factor alpha agents, ustekinumab, secukinumab, ixekizumab, and others;Puig;Curr Probl Dermatol,2018
4. Paradoxical reactions to biologic therapy in psoriasis: a review of the literature;Munera-Campos;Actas Dermosifiliogr,2018
5. Effective treatment with guselkumab for psoriatic alopecia as paradoxical reaction;Hosokawa;J Dermatol,2019
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献